Sight Sciences, Inc. insider trading
Every open-market purchase and sale by Sight Sciences, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Sight Sciences, Inc.’s insiders pay?
From October 20, 2021 to June 11, 2026, 12 insiders reported 19 open-market purchases and 53 sales not made under a pre-set plan in Sight Sciences, Inc. Twelve months after each purchase was reported, the shares were −27.3% against the S&P 500 on average (median −34.8%), over 5 purchases with a full year of prices; 0% beat the index. After sales, the shares moved −58.3% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on October 21, 2021 into $4,738 by November 2, 2026, −13.9% a year. It held shares 48% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $12,026 (+3.8% a year), and held throughout $17,831 (+12.2%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Encrantz Staffan | Director | 13 | −31.9% (3) | 0% | 1 | — | June 11, 2026 |
| Badawi David | Chief Technology Officer | 0 | — | — | 11 | −63.3% (4) | January 6, 2026 |
| Badawi Paul | President and CEO | 0 | — | — | 10 | −63.3% (4) | January 6, 2026 |
| Bauerlein Alison | Chief Operating Officer | 0 | — | — | 10 | −56.9% (4) | January 6, 2026 |
| Hayden Jeremy B. | Chief Legal Officer | 0 | — | — | 9 | −63.3% (4) | October 3, 2025 |
| Link Matthew | Chief Commercial Officer | 0 | — | — | 4 | −23.1% (2) | July 7, 2025 |
| Park Sam Boong | Chief Operating Officer | 0 | — | — | 4 | −63.3% (4) | October 3, 2024 |
| Raheja Manohar K. | EVP, Research & Development | 4 | — | — | 0 | — | March 13, 2025 |
| Rodberg James | Chief Financial Officer | 0 | — | — | 2 | — | January 6, 2026 |
| Selnick Jesse | Chief Financial Officer | 2 | −20.4% (2) | 0% | 0 | — | May 17, 2022 |
| D1 Capital Partners L.P. | 10% owner | 0 | — | — | 1 | −55.1% (1) | December 29, 2023 |
| Taylor Brenton | EVP, Operations & R&D | 0 | — | — | 1 | — | November 18, 2025 |
When several insiders traded Sight Sciences, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Sight Sciences, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged −13.5% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| May 31, 2022 | 2 buying | −15.2% | +23.2% | +7.4% |
| November 30, 2021 | 2 buying | −13.1% | −50.2% | −37.5% |